5 Stocks To Watch For September 21, 2017

Some of the stocks that may grab investor focus today are:

  • Herman Miller, Inc. (NASDAQ:MLHR) reported in-line earnings for its first quarter, while sales exceeded estimates. Herman Miller shares slipped 2.72 percent to $34.00 in the after-hours trading session.
  • Wall Street expects Manchester United PLC (NYSE:MANU) to report quarterly earnings at $7.88 per share on revenue of $205.85 million before the opening bell. Manchester United shares declined 0.58 percent to $17.10 in after-hours trading.
  • Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) reported the FDA approval for Sodium Bicarbonate injection. Amphastar Pharmaceuticals shares gained 2.94 percent to $16.10 in the after-hours trading session.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • Anadarko Petroleum Corporation (NYSE:APC) disclosed a $2.5 billion share-buyback program. Anadarko Petroleum shares climbed 4.69 percent to $46.91 in after-hours trading.
  • ABIOMED, Inc. (NASDAQ:ABMD) announced the FDA pre-market approval for the Impella RP® heart pump. ABIOMED shares surged 2.91 percent to $162.00 in the after-hours trading session.
Posted In: EarningsNewsFDAPre-Market OutlookMarketsTrading IdeasStocks To WatchStocks to Watch